# Tenofovir Alafenamide With Fine Needle Aspiration Biopsy in Chronic Hepatitis B:

> **NCT04070079** · PHASE4 · UNKNOWN · sponsor: **University Health Network, Toronto** · enrollment: 15 (estimated)

## Conditions studied

- Hepatitis B, Chronic

## Interventions

- **DRUG:** Tenofovir Alafenamide

## Key facts

- **NCT ID:** NCT04070079
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-29
- **Primary completion:** 2022-08-30
- **Final completion:** 2022-12-31
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2019-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04070079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04070079, "Tenofovir Alafenamide With Fine Needle Aspiration Biopsy in Chronic Hepatitis B:". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04070079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*